TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ERAS

Erasca Inc

Healthcare · Biotechnology

15.00$ +1.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ERAS
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
92.1% 96.1% 83.8% 86.3% 81.1% 61.4% 72.3%
53.3% 52.4% 71.9% 55.2% 23.5% 13.5% 18.6%
90.7% 95.1% 91.6% 84.6% 79.0% 59.4% 69.7%
0.0% 0.5% 0.6%
7.8% 3.3% 3.2% 4.8%
124.5% 191.3% 9.0% 20.0% 19.9% 15.7% 17.9%
5.0% 11.0% 5.3% 9.5% 6.6% 6.2% 7.2%
1.3% 0.7% 0.1% 0.5% 1.0% 1.8% 1.3%
2.5% 0.7% 0.9% 4.5% 0.5% 0.1% 0.2%
-24.5% -91.3% 91.0% 80.0% 80.1% 84.3% 82.1%
-24.8% -92.5% -47.5% -93.4% -153.3% -152.8% -225.2%
171.4% 14.9% 19.0% 19.0% 30.4% 46.5% 71.6%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?